BBP-418

N/A

Report date: 2025/11/04 20:00:06
NME

Base Information

Drug NameBBP-418
Drug Alias NameAdonitolRibitolBBP-418
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionGlycosylation stimulants
TargetsNot applicable
Therapy Area/IndicationsLimb girdle muscular dystrophy 2ILimb girdle muscular dystrophy 2A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsNorway +[8] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtrium HealthMl Bio Solutions Inc
China Registration ClassN/A

Develop Information

Active CompaniesMl Bio Solutions Inc
Inactive CompaniesN/A
Active IndicationsLimb girdle muscular dystrophy 2ILimb girdle muscular dystrophy 2A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A